APA (7th ed.) Citation

F, B., M, F., P, S., S, N., Z, K., O, J., . . . J, M. (2025). Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 31, 10760296251341315. https://doi.org/10.1177/10760296251341315

Chicago Style (17th ed.) Citation

F, Burša, et al. "Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 31 (2025): 10760296251341315. https://doi.org/10.1177/10760296251341315.

MLA (9th ed.) Citation

F, Burša, et al. "Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation." Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, vol. 31, 2025, p. 10760296251341315, https://doi.org/10.1177/10760296251341315.